B. Fredholm, K. Battig, J. Holmen, A. Nehlig, and E. Zvartau, Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol Rev, vol.51, issue.1, pp.83-133, 1999.

J. Daly and B. Fredholm, Caffeine ??? an atypical drug of dependence, Drug and Alcohol Dependence, vol.51, issue.1-2, pp.199-206, 1998.
DOI : 10.1016/S0376-8716(98)00077-5

J. Ribeiro, A. Sebastiao, and A. De-mendonca, Adenosine receptors in the nervous system: pathophysiological implications, Progress in Neurobiology, vol.68, issue.6, pp.377-392, 2002.
DOI : 10.1016/S0301-0082(02)00155-7

G. Cunha, P. Canas, J. Chen, C. Oliveira, R. Cunha et al., Blockage of adenosine A2A receptors prevents beta-amiloid (Abeta1-42)-induced synaptotoxicity and memory impairment in rodents Purinergic Signalling 2, 135. [5] Dall Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production, Exp Neurol. Neuroscience, vol.6, issue.142, pp.941-952, 2006.

G. Arendash, T. Mori, C. Cao, M. Mamcarz, M. Runfeldt et al., Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-?? Levels in Aged Alzheimer's Disease Mice, Journal of Alzheimer's Disease, vol.17, issue.3, pp.661-680, 2009.
DOI : 10.3233/JAD-2009-1087

P. Gateau and M. Ancelin, The neuroprotective effects of caffeine: a prospective population study (the Three City Study), Neurology, vol.69, pp.536-545, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00168786

L. Maia and A. De-mendonca, Does caffeine intake protect from Alzheimer's disease?, European Journal of Neurology, vol.8, issue.4, 2002.
DOI : 10.1001/archneur.57.6.839

J. Lindsay, D. Laurin, R. Verreault, R. Hebert, B. Helliwell et al., Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and Aging, American Journal of Epidemiology, vol.156, issue.5, pp.445-453, 2002.
DOI : 10.1093/aje/kwf074

M. Eskelinen, T. Ngandu, J. Tuomilehto, H. Soininen, and M. Kivipelto, Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study, Journal of Alzheimer's Disease, vol.16, issue.1, pp.85-91, 2009.
DOI : 10.3233/JAD-2009-0920

M. Johnson-kozlow, D. Kritz-silverstein, E. Barrett-connor, and D. Morton, Coffee Consumption and Cognitive Function among Older Adults, American Journal of Epidemiology, vol.156, issue.9, pp.842-850, 2002.
DOI : 10.1093/aje/kwf119

M. Van-boxtel, J. Schmitt, H. Bosma, and J. Jolles, The effects of habitual caffeine use on cognitive change: a longitudinal perspective, Pharmacology Biochemistry and Behavior, vol.75, issue.4, pp.921-927, 2003.
DOI : 10.1016/S0091-3057(03)00171-0

P. Hameleers, V. Boxtel, M. Hogervorst, E. Riedel, W. Houx et al., Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups, Human Psychopharmacology: Clinical and Experimental, vol.32, issue.8, pp.573-581, 2000.
DOI : 10.1002/hup.218

A. Hill, The environment and disease: association or causation?, Journal of the Royal Society of Medicine, vol.88, issue.1, pp.295-300, 1965.
DOI : 10.1177/0141076814562718

M. Gurol, M. Irizarry, E. Smith, S. Raju, R. Diaz-arrastia et al., Plasma ??-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy, Neurology, vol.66, issue.1, pp.23-29, 2006.
DOI : 10.1212/01.wnl.0000191403.95453.6a

A. Brickman, J. Muraskin, and M. Zimmerman, Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?, Dialogues Clin Neurosci, vol.11, pp.181-190, 2009.

3. The and . Group, Vascular factors and risk of dementia: Design of the three city study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

H. Lieberman, The Effects of Ginseng, Ephedrine, and Caffeine on Cognitive Performance, Mood and Energy, Nutrition Reviews, vol.59, issue.4, pp.91-102, 2001.
DOI : 10.1111/j.1753-4887.2001.tb06995.x

A. Brickman, A. Zahra, J. Muraskin, J. Steffener, C. Holland et al., Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging, Psychiatry Research: Neuroimaging, vol.172, issue.2, pp.117-120, 2009.
DOI : 10.1016/j.pscychresns.2008.11.006

C. Rorden and M. Brett, Stereotaxic Display of Brain Lesions, Behavioural Neurology, vol.12, issue.4, pp.191-200, 2000.
DOI : 10.1155/2000/421719

I. Carriere, A. Fourrier-reglat, J. Dartigues, O. Rouaud, F. Pasquier et al., Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population, Archives of Internal Medicine, vol.169, issue.14, pp.1317-1324, 2009.
DOI : 10.1001/archinternmed.2009.229

URL : https://hal.archives-ouvertes.fr/inserm-00415864

L. Radloff, The CES-D Scale: A Self-Report Depression Scale for Research in the General Population, Applied Psychological Measurement, vol.1, issue.3, pp.385-401, 1977.
DOI : 10.1177/014662167700100306

J. Chen, P. Sonsalla, F. Pedata, A. Melani, M. Domenici et al., Adenosine A2A receptors and brain injury: Broad spectrum of neuroprotection, multifaceted actions and ???fine tuning??? modulation, Progress in Neurobiology, vol.83, issue.5, pp.310-331, 2007.
DOI : 10.1016/j.pneurobio.2007.09.002